NEW YORK - TelAve -- Tutanota LLC ("Purchaser") announces that its previously-announced tender offer (the "Offer") to acquire up to 1,000,000 shares of common stock (the "Shares") of Pfizer, Inc. for $32.00 per Share (the "Offer Price"), less applicable dividends, has been extended to 5:00 p.m., New York City time, on Friday, December 11, 2026, unless further extended or earlier terminated (the "Expiration Date"). The Offer was previously scheduled to expire at 5:00 p.m., New York City time, on Monday, April 13, 2026. All other terms and conditions of the Offer remain unchanged.

Shareholders who have already tendered their Shares do not have to re-tender their Shares or take any other action due to extension of the Offer's expiration date.

The Offer is subject to closing conditions set forth in the Offer to Purchase, dated March 9, 2026, including the closing price of the Shares on the NYSE on the last full trading day prior to the Expiration Date exceeding the Offer Price and Purchaser obtaining financing necessary to fund Purchaser's financial obligations arising from the Offer.

This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell shares or any other securities. The Offer to Purchase common stock of Applied Materials, Inc. is only being made pursuant to the Offer to Purchase and Letter of Transmittal with respect to the Offer, as such documents may be supplemented and amended from time to time. Shareholders are urged to read these materials carefully because they contain important information, included the terms and conditions of the Offer, that shareholders should consider before making any decision regarding tendering their Shares. Shareholders can obtain a copy of the Offer to Purchase and Letter of Transmittal with respect to the Offer by contacting the information agent at (888) 519-8569 OR CONTACT@INFO-AGENT.COM. Copies of these materials and any documentation relating to the Offer are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in, into or from any jurisdiction where to do so would be unlawful.

More on TelAve News

• Card makers turn to Pink and Main for tools to support their craft
• Revenue Optics Completes Full Commercial Buildout. A Nine-Month-Old Firm Built on 25 Years of Distribution Expertise. Five Clients From $200M to $3B
• EduCare Inc. Bridges Critical Gap in Breast Cancer Education with Spanish COPE Library Launch
• Engineering leaders from industry, academia to gather at IISE Annual Conference & Expo in Arlington, Texas
• AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)

Tutanota LLC is a private investment company that specializes in investing in publicly traded securities.

Forward Looking Statements

Statements included in this press release that are not historical facts are forward-looking statements, which involve a number of risks and uncertainties and are subject to change at any time.  While Purchaser may elect to update forward-looking statements in the future, Purchaser specifically disclaims any obligation to do so, even if estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.